Esoteric Testing Market to 2023 - Find Out Top Impacting Factor of Growth by Opportunity and Industry Forecast
Esoteric testing market major factors driving growth of market in North American region include accessibility to advanced technologies, presence of a well-established network of independent & reference laboratories, expansion of molecular diagnostics for
(EMAILWIRE.COM, February 05, 2019 ) Esoteric testing market is projected to reach USD 35.24 billion by 2023 from USD 20.38 billion in 2018, at a CAGR of 11.6%. Growth in this market is primarily driven by increasing burden of chronic diseases (majorly due to rising geriatric population), rising prevalence of infectious diseases, rising demand for early disease diagnosis using specialized tests, growing awareness on personalized medicine, and increasing government funding for the research and development of innovative esoteric tests.
#Download Free PDF of Esoteric Testing Market Report Now available at <||>rnhttps://www.reportsnreports.com/contacts/requestsample.aspx?name=1308706 .
The esoteric testing market report studies factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. Geographically, the esoteric testing market is segmented into North America, Europe, Asia Pacific, Rest of Latin America, and Middle East & Africa. In 2018, North America is expected to account for the largest share of the market followed by Europe.
The prominent players in esoteric testing market include LabCorp (US), OPKO Health (US), ARUP Laboratories (US), Miraca Holdings (Japan), Myriad Genetics (US), Genomic Health (US), Quest Diagnostics (US), American Medical Laboratories (US), Foundation Medicine (US), Mayo Medical Laboratories (US), Primary Healthcare (Australia), Healthscope (Australia), Sonic Healthcare (Australia), Fulgent Genetics (US), Invitae (US), Spectra Laboratories (US), Eurofins Scientific (Luxembourg), Unilabs (Switzerland), SYNLAB International (Germany), Enzo Biochem (US), Clinical Reference Laboratory (US), Sequenom (US), and American Pathology Partners (US).
Click Here for More Details Now at https://www.whatech.com/market-research/industrial/551386-esoteric-testing-market-set-to-reach-us-35-24-billion-by-2023-growing-at-11-6-cagr-led-by-europe-south-east-asia-and-north-america-region .
Geographically, the esoteric testing market is divided in North America, Europe, Asia Pacific, Rest of Latin America, and Middle East & Africa. In 2018, North America is expected to account for the largest share of the market followed by Europe.
Objectives of the study are:
To define, describe, and forecast the global market by type, technology, and laboratory type
To provide detailed information regarding major factors influencing the growth of the market (drivers, restraints, opportunities, challenges, and industry trends)
To analyze various segments covered in the study with respect to individual growth trends, prospects, and contributions to the overall market
To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
To strategically profile key players in this market and comprehensively analyze their market shares and core competencies
To forecast the market size of the global market with respect to the five key regions (along with countries), namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
To track and analyze competitive developments such as joint ventures, agreements, and partnerships; mergers and acquisitions; product launches; and research and development activities in the global market.
Order the Report on Esoteric Testing Market by Type (Infectious Disease, Endocrinology, Oncology, Toxicology, Immunology, Neurology, Genetic Testing), Lab Type (Independent Labs, Hospital Laboratories), Technology (Mass Spectrometry, CLIA, ELISA, PCR) - Global Forecast to 2023 report at https://www.reportsnreports.com/purchase.aspx?name=1308706 .
Target Audience for esoteric testing Report are Independent/reference laboratories, Clinical laboratory testing service providers, Diagnostic companies, Suppliers and distributors of diagnostic test kits, OEM manufacturers, Healthcare service providers (including hospital-affiliated laboratories). This report is also useful for Medical institutes, Health insurance players, Pharmaceutical, biopharmaceutical, and biotechnology companies, Market research and consulting firms.
Breakdown of supply-side primary interviews: by company type, designation, and region:
By Company Type - Tier 1 48%, Tier 2 40% and Tier 3 12%
By Designation C-level 26%, Director-level 30%, Others 44%
By Region North America - 34%, Europe 26%, APAC 23%, RoW 17%
#Download Free PDF of Esoteric Testing Market Report Now available at <||>rnhttps://www.reportsnreports.com/contacts/requestsample.aspx?name=1308706 .
The esoteric testing market report studies factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. Geographically, the esoteric testing market is segmented into North America, Europe, Asia Pacific, Rest of Latin America, and Middle East & Africa. In 2018, North America is expected to account for the largest share of the market followed by Europe.
The prominent players in esoteric testing market include LabCorp (US), OPKO Health (US), ARUP Laboratories (US), Miraca Holdings (Japan), Myriad Genetics (US), Genomic Health (US), Quest Diagnostics (US), American Medical Laboratories (US), Foundation Medicine (US), Mayo Medical Laboratories (US), Primary Healthcare (Australia), Healthscope (Australia), Sonic Healthcare (Australia), Fulgent Genetics (US), Invitae (US), Spectra Laboratories (US), Eurofins Scientific (Luxembourg), Unilabs (Switzerland), SYNLAB International (Germany), Enzo Biochem (US), Clinical Reference Laboratory (US), Sequenom (US), and American Pathology Partners (US).
Click Here for More Details Now at https://www.whatech.com/market-research/industrial/551386-esoteric-testing-market-set-to-reach-us-35-24-billion-by-2023-growing-at-11-6-cagr-led-by-europe-south-east-asia-and-north-america-region .
Geographically, the esoteric testing market is divided in North America, Europe, Asia Pacific, Rest of Latin America, and Middle East & Africa. In 2018, North America is expected to account for the largest share of the market followed by Europe.
Objectives of the study are:
To define, describe, and forecast the global market by type, technology, and laboratory type
To provide detailed information regarding major factors influencing the growth of the market (drivers, restraints, opportunities, challenges, and industry trends)
To analyze various segments covered in the study with respect to individual growth trends, prospects, and contributions to the overall market
To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
To strategically profile key players in this market and comprehensively analyze their market shares and core competencies
To forecast the market size of the global market with respect to the five key regions (along with countries), namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
To track and analyze competitive developments such as joint ventures, agreements, and partnerships; mergers and acquisitions; product launches; and research and development activities in the global market.
Order the Report on Esoteric Testing Market by Type (Infectious Disease, Endocrinology, Oncology, Toxicology, Immunology, Neurology, Genetic Testing), Lab Type (Independent Labs, Hospital Laboratories), Technology (Mass Spectrometry, CLIA, ELISA, PCR) - Global Forecast to 2023 report at https://www.reportsnreports.com/purchase.aspx?name=1308706 .
Target Audience for esoteric testing Report are Independent/reference laboratories, Clinical laboratory testing service providers, Diagnostic companies, Suppliers and distributors of diagnostic test kits, OEM manufacturers, Healthcare service providers (including hospital-affiliated laboratories). This report is also useful for Medical institutes, Health insurance players, Pharmaceutical, biopharmaceutical, and biotechnology companies, Market research and consulting firms.
Breakdown of supply-side primary interviews: by company type, designation, and region:
By Company Type - Tier 1 48%, Tier 2 40% and Tier 3 12%
By Designation C-level 26%, Director-level 30%, Others 44%
By Region North America - 34%, Europe 26%, APAC 23%, RoW 17%
Contact Information:
ReportsnReports
Vishal
Tel: + 18883915441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsnReports
Vishal
Tel: + 18883915441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results